Golden Minerals Stock (AMEX:AUMN), Trade Ideas

Golden Minerals

Golden Minerals Co is an exploration stage company engaged in the mining, construction, and exploration of precious metals and mineral properties. It owns and operates Velardena and Chicago precious metals mining properties and associated oxide and sulfide processing plants in the State of Durango, Mexico, the El Quevar exploration property in the province of Salta, Argentina, and a diversified portfolio of precious metals and other mineral exploration properties located in or near historical precious metals producing regions of Mexico. The company's business is structured into two divisions, Mexico operations, and Corporate Exploration and Other.

Mining,Cart,In,Silver,,Gold,,Copper,Mine

Equities

Commodities

Markets

AUMN

FMST

GOLD

Top stories: Lithium exploration, Barrick Gold withdraws from Argentina project, Cleveland-Cliffs raises steel prices, Freeport-McMoRan declares dividend.

Foremost Lithium Reports Drilling Progress; Barrick Gold Withdraws From Silver Project; Cleveland-Cliffs Raises Prices And More: Wednesday&#39;s Top Mining Stories

lithium mining ai

Earnings

AMSYF

MTAL

NEXA

VALE

Top stories: Nexa Resources suspends mining operations, Metals Acquisition reports high copper grades, Golden Minerals releases financial results, ArcelorMittal names new CEO for mining division.

Nexa Resources Suspends Morro Agudo Operations; Metals Acquisition Reports Drilling Results; Golden Minerals Shares FY 2023 Results And More: Tuesday&#39;s Top Mining Stories

Penny Stocks

Small Cap

AUST

Top Stories for March 5, 2024:
1. MP Materials Corp. (NYSE: MP) announced a private offering of $650 million in 3.00% convertible notes due in 2030 to qualified institutional buyers, with an option for initial purchasers to buy up to an additional $97.5 million within 13 days.

MP Materials, Cleveland-Cliffs Increase Offerings; Austin Gold Finishes Initial Drilling Program And More: Tuesday&#39;s Top Mining Stories

Golden Minerals Co

Top Stories for March 27, 2024:
<ol>
<li>Foremost Lithium Resource &amp; Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FMST#NASDAQ">FMST</a>) is engaged in lithium exploration in Manitoba&#8217;s Snow Lake region and reported <a href="https://www.benzinga.com/news/24/03/37955431/exclusive-foremost-lithium-reports-widest-intercept-of-spodumene-bearing-pegmatite-at-zoro-lithium-p">significant drilling progress</a> at the Zoro Lithium Property.&nbsp;</li>
</ol>
The company highlighted a substantial drill intercept of 32.53 meters of spodumene-bearing pegmatite at Dyke 1, which contains an inferred resource of over 1 million tons at 0.91% Li2O.&nbsp;
Recent drilling has focused on Dyke 1&#8217;s southern extension, seen as a priority due to its underexplored status, and early drilling confirmed spodumene presence with samples sent for assay analysis.&nbsp;
With 10 drill holes and approximately 2,100 meters completed, the company aims to further understand the mineralization to support an updated resource estimate.
When asked for a quote, President and CEO of Foremost Jason Barnard said: "I feel this is very positive for the potential of our maiden resource to now grow in significant scale. We may have hit a new discovery to the south of our dyke 1, in a new unchartered area and feel really encouraged for our company and shareholders. We look forward to our pending assays results and  further drill results as it continues to progress."
<ol start="2">
<li>Barrick Gold Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>) informed Golden Minerals Company (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AUMN#AMEX">AUMN</a>) that it will withdraw from their earn-in agreement on the El Quevar silver project in Argentina, effective April 20, 2024. </li>
</ol>
This project was signed in April 2020 and aimed at Barrick earning a 70% interest by investing $10 million over eight years and delivering a pre-feasibility study.&nbsp;
Barrick has already spent over $6 million and completed a five-hole, 1,300-meter drill program that identified a potential gold prospect.&nbsp;
Golden Minerals is pivoting from production to exploration and development and views the project&#8217;s return positively, noting El Quevar&#8217;s potential for advancing silver and gold prospects.
Also Read:<a href="https://www.benzinga.com/topic/mining"> </a><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37942317/gold-mining-stocks-eye-best-month-in-a-year-as-golden-era-for-the-precious-metal-lo">Gold Mining Stocks Eye Best Month In A Year As &#8216;Golden Era&#8217; For The Precious Metal Looms</a>
<ol start="3">
<li>Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) raised its spot market base prices by $60 per net ton for carbon hot rolled, cold rolled and coated steel products, effective immediately on all new orders.&nbsp;</li>
</ol>
The new minimum base price for hot rolled steel is $900 per net ton.
<ol start="4">
<li>Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) declared a 15-cents-per-share dividend, consisting of a 7.5-cent base and a 7.5-cent variable dividend, payable on May 1, 2024 to shareholders as of April 15, 2024.</li>
</ol>
Now Read:<a href="https://www.benzinga.com/"> </a><a href="https://www.benzinga.com/news/24/03/37948764/bridge-collapse-snarls-consol-energy-coal-exports-from-port-of-baltimore">Bridge Collapse Snarls Consol Energy Coal Exports From Port Of Baltimore</a>
Benzinga Mining is the bridge between mining companies and retail investors. Reach out to <a href="mailto:licensing@benzinga.com">licensing@benzinga.com</a> to get connected with the Benzinga community!
Photo via Shutterstock.

Foremost Lithium Reports Drilling Progress; Barrick Gold Withdraws From Silver Project; Cleveland-Cliffs Raises Prices And More: Wednesday's Top Mining Stories

Top Stories for March 19, 2024:
1. Nexa Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEXA#NYSE">NEXA</a>) announced the <a href="https://www.benzinga.com/topic/mining">suspension of mining operations</a> at the Morro Agudo Complex in Minas Gerais, Brazil, starting May 1, 2024. 
Mining activities will slow until the end of April 2024, while limestone production continues at full capacity.&nbsp;
In 2023, Morro Agudo produced 23 karats of zinc and 8.3 karats of lead, with no estimated mineral reserves.&nbsp;
The Ambrósia mine reached the end of its life in late 2020 and operations have since been suspended as part of Nexa&#8217;s strategy to optimize its portfolio, improve cash flow and maximize shareholder value.&nbsp;
The Morro Agudo Complex contributes 5% and 6% to Nexa&#8217;s monthly zinc and lead production, respectively, and the 2024 financial outlook for Nexa remains unchanged.
2. Metals Acquisition Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTAL#NYSE">MTAL</a>) gave an update on its ongoing exploration and resource development at the CSA Copper <a href="https://metalsacquisition.com/investor-relations/news/news-details/2024/Metals-Acquisition-Limited-Reports-Drill-Results-Including-19.2m--10.4-Cu-16.0m--10.4-Cu-and-3m--13.9-Cu/default.aspx">Mine</a>. 
Results from the exploration are after the August 31, 2023, cutoff and feature high copper grades across several areas, including 14m at 7.9% Cu, 16m at 10.4% Cu and 19.2m at 10.4% Cu from QTS North.
The company also reported high-grade findings from QTS Central and QTS South Upper A, with copper grades up to 21.3%.&nbsp;
The exploration was initiated after the company's acquisition of the CSA Copper mine in June 2023, and aims to expand the high-quality resource base for a new reserve estimate and mine plan.&nbsp;
Also Read:<a href="https://www.benzinga.com/topic/mining"> </a><a href="https://www.benzinga.com/markets/commodities/24/03/37822526/copper-prices-surge-to-11-month-high-amid-supply-concerns-freeport-ceo-to-politicos-stop-givi">Copper Prices Surge To 11-Month High Amid Supply Concerns, Freeport CEO To Politicos: &#8216;Stop Giving Lip Service&#8217;</a>
3. Golden Minerals Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AUMN#NYSE">AUMN</a>) reported its financial results and activities for the fiscal year ending Dec. 31, <a href="https://www.goldenminerals.com/news/2024/golden-minerals-reports-full-year-2023-results">2023</a>.
Golden Minerals' 2023 revenue was $12 million, down from $23.3 million in 2022, with a net loss of $9.2 million, an improvement over the previous year&#8217;s $9.9 million loss.
The company processed and sold 3,000 tons from Velardeña between March and September 2023.&nbsp;
Mining at Velardeña began in December 2023 but stopped by February 2024 due to poor performance, prompting a potential short-term sale of the properties.&nbsp;
Its Rodeo mine ceased operations in June 2023, producing 31,126 ounces of gold and 126,151 ounces of silver by year&#8217;s end, with cash costs at $1,275 per ounces of gold.&nbsp;
Initial estimates at the Yoquivo property showed 937,000 tons with 12.3 million ounces of silver and 64,000 ounces of gold.&nbsp;
Finally, the company sold its Santa Maria property in December 2023 for $1.5 million, plus a 1.5% smelter royalty.&nbsp;
4. ArcelorMittal (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AMSYF#OTC">AMSYF</a>) announced Kleber Silva as the new Executive Vice President and CEO of ArcelorMittal Mining, starting April 8, 2024. 
Silva brings 35 years of extensive experience in the mining and metals industry, having held senior roles at MBR, Vale S.A (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VALE#NYSE">VALE</a>) and previously at ArcelorMittal, where he led significant operations and strategic projects.
Now Read:<a href="https://www.benzinga.com/"> </a><a href="https://www.benzinga.com/markets/commodities/24/03/37789877/bhp-to-slash-australian-workforce-as-nickel-market-downturn-continues">BHP To Slash Australian Workforce As Nickel Market Downturn Continues</a>
Benzinga Mining is the bridge between mining companies and retail investors. Reach out to <a href="mailto:licensing@benzinga.com">licensing@benzinga.com</a> to get connected with the Benzinga community!
Image created using artificial intelligence with Midjourney.

Nexa Resources Suspends Morro Agudo Operations; Metals Acquisition Reports Drilling Results; Golden Minerals Shares FY 2023 Results And More: Tuesday's Top Mining Stories

<ul>
<li>Total 2023 revenue was&nbsp;$12.0 million, including the sale of metals from the Rodeo mine as well as revenue from slag and concentrate sales at Velarde&ntilde;a. Total revenue was&nbsp;$23.3 million&nbsp;in 2022, which was attributable solely to the sale of metals from the Rodeo mine.</li>
<li>2023 cost of metals sold was&nbsp;$12.4 million&nbsp;(including costs from both Rodeo and Velarde&ntilde;a) vs.&nbsp;$17.5 million&nbsp;in 2022, which included only Rodeo costs.</li>
<li>Exploration expenses were&nbsp;$3.4 million&nbsp;in 2023 vs.&nbsp;$9.6 million&nbsp;in 2022.</li>
<li>Velarde&ntilde;a care and maintenance expenses were&nbsp;$1.2 million&nbsp;in 2023 vs.&nbsp;$1.4 million&nbsp;in 2022.</li>
<li>Administrative expenses were&nbsp;$4.7 million&nbsp;in 2023 vs.&nbsp;$4.5 million&nbsp;in 2022.</li>
<li>Other operating income was&nbsp;$2.3 million&nbsp;in 2023 vs.&nbsp;$1.6 million&nbsp;in 2022.</li>
<li>Net loss was&nbsp;$9.2 million, or&nbsp;$1.08&nbsp;per share, in 2023 compared to a net loss of&nbsp;$9.9 million, or&nbsp;$1.49&nbsp;per share, in 2022.</li>
<li>Cash and equivalents balance was&nbsp;$3.8 million&nbsp;as of December 31, 2023 vs.&nbsp;$4.0 million&nbsp;as of December 31, 2022.</li>
<li>Debt was zero as of December 31, 2023, which is unchanged from December 31, 2022.</li>
</ul>

News

Golden Minerals Co Reports FY23 Revenue of $12.0M, down from $23.3M YoY Vs $19.8M Est, EPS Loss of $(1.08) Vs $(1.49) YoY

Top Stories for March&nbsp;5, 2024: 
1. MP Materials Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mp#NYSE">MP</a>) announced a private offering of $650 million in 3.00% convertible notes due in 2030 to qualified institutional buyers, with an option for initial purchasers to buy up to an additional $97.5 million within 13 days.
The offering reported on Monday was <a href="https://www.benzinga.com/news/24/03/37456026/whats-going-on-with-mp-materials-stock-today">increased from $500 million</a>, and is set to close on March 7, 2024.
Additionally, the company engaged in capped call transactions to raise the conversion premium to 100%, repurchased 12.3 million shares for about $191.6 million and used roughly $358.4 million of the proceeds to buy back $400 million of its 2026 convertible notes.
2. Cleveland-Cliffs Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/clf#NYSE">CLF</a>) is also upsizing its $750 million offering reported Monday to $825 million of senior unsecured guaranteed notes due in 2032.
The notes will be issued at par and bear annual interest rates of 7%, with the offering expected to close on March 18, 2024.
The company still intends to use the proceeds and current liquidity on hand to repurchase all of its 6.75% Senior Secured Notes due in 2026.
3. Austin Gold (AMEX: AUST) finished the initial diamond drilling program at its Stockade Mountain Project in Malheur County, Oregon, drilling three holes totaling 2,435.9 feet. The final hole reached a depth of 736.7 feet.
Core samples are now with an assay lab for testing, but early results show significant gold grades, including a high of 8.19 g/t (grams per ton) gold over four feet.
Austin plans a reverse circulation drilling program for the summer and is fully funded for upcoming exploration activities. Results from the current assays are expected in four to six weeks.
4. Loop Capital analyst Chris Kapsch downgraded Compass Minerals Intl. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cmp#NYSE">CMP</a>) from Buy to Hold, and lowered his price target from $29 to $26.
5. Golden Minerals Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aumn#NYSE">AUMN</a>) announced the passing of one of its board members, W. Durand Eppler.
Now Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37494246/bitcoin-set-for-worst-day-in-16-months-after-major-reversal-from-all-time-high-chart-shows">Bitcoin Set For Worst Day In 16 Months After Major Reversal From All-Time High: Chart Shows 2 Bearish Signals</a> 
Photo: Shutterstock

MP Materials, Cleveland-Cliffs Increase Offerings; Austin Gold Finishes Initial Drilling Program And More: Tuesday's Top Mining Stories

Top Stories for Feb. 29, 2024:
1. Jefferies analyst Matthew Murphy initiated coverage on Royal Gold (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgld#NASDAQ">RGLD</a>) with a Hold rating and announced a Price Target of $117.
2. Golden Minerals Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aumn#NYSE">AUMN</a>) stopped mining operations at its Velarde&ntilde;a Properties in Mexico.
After restarting operations in late December 2023, the initial performance of the mine and processing plant over the first months did not achieve the projected results.
The company is now exploring potential alternatives, including a sale of the properties or winding up of some of its Mexico operations.
3. The world&rsquo;s largest global mining company BHP Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bhp#NYSE">BHP</a>) has started restructuring its global operations, starting in Australia, where it is facing a slowdown in the nickel market.
Management is looking to cut costs and improve productivity overall, but particularly in Australia following concerns over wage inflation.
CEO Mike Henry believes the nickel industry in the region needs more than Australian federal tax credits and royalty relief to stop the shutdown of its Western Australia site.
In light of the situation, Australian Prime Minister Anthony Albanese stated that the government is considering &quot;providing further support with a smart, targeted and time-limited policy.&quot;
4. Board Member James Donald Hoffman of Reliance (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rs#NYSE">RS</a>) made an insider sale of 40,000 shares on Wednesday, Feb. 28 for a total of $12,917,867.
5. ArcelorMittal (OTC: <a class="ticker" href="https://www.benzinga.com/stock/amsyf#OTC">AMSYF</a>), the largest steel producer in Europe and among the largest in the Americas, published its 2023 annual report.
The company reported $68.3 billion in revenue, produced 58.1 million metric tons of crude steel, 42 million metric tons of iron ore and shipped 55.6 million metric tons of steel in 2023.
This compared to the previous year&rsquo;s $79.8 billion&nbsp;in revenue, 59 million metric tons of crude steel, 45.3 million metric tons of iron ore and 55.9 million metric tons of steel shipped.
Now Read:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37406620/merrill-and-wells-fargo-jump-on-board-bitcoin-etfs-reach-wall-street-elite">Merrill And Wells Fargo Jump On Board: Bitcoin ETFs Reach Wall Street Elite</a>
Photo: Shutterstock

RGLD

Jefferies Covers Royal Gold; Golden Minerals Halts Velardeña; BHP Restructures Global Ops And More: Thursday's Mining Highlights

Shares of Butterfly Network, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfly#NASDAQ">BFLY</a>) fell sharply during Thursday&rsquo;s session after the company reported mixed fourth-quarter financial results.
Butterfly Network posted GAAP loss of 21 cents per share versus market estimates for a loss of 14 cents per share. The company&rsquo;s quarterly sales came in at sales came in $16.52 million versus estimates of $15.35 million.
Butterfly Network shares dipped 21.7% to $1.1588 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Enveric Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/envb#NASDAQ">ENVB</a>) gained 177.1% to $2.30 after the company announced it has signed three non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of compounds.</li>
<li>Societal CDMO, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sctl#NASDAQ">SCTL</a>) shares climbed 132.7% to $1.07 as the company agreed to be acquired by CoreRx, Inc.</li>
<li>Volcon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vlcn#NASDAQ">VLCN</a>) gained 55.4% to $1.8802 after surging around 39% on Wednesday.</li>
<li>Sidus Space, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sidu#NASDAQ">SIDU</a>) climbed 39.7% to $7.78.</li>
<li>Ocean Biomedical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocea#NASDAQ">OCEA</a>) gained 36.4% to $2.1008. Ocean Biomedical announced joint venture partner, Virion Therapeutics to present clinical study data at 2024 APASL Global Liver Meeting.</li>
<li>Inseego Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/insg#NASDAQ">INSG</a>) rose 34.5% to $3.00.</li>
<li>Vertex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verx#NASDAQ">VERX</a>) jumped 29.8% to $32.97 after the company reported better-than-expected fourth-quarter results and issued strong FY24 guidance.</li>
<li>iHeartMedia, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ihrt#NASDAQ">IHRT</a>) rose 29.1% to $2.93 following fourth-quarter results.</li>
<li>Agrify Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agfy#NASDAQ">AGFY</a>) gained 27% to $0.6161. Agrify announced a $3.4 million sales order from New Jersey woman-owned business HarvestWorks Farm.</li>
<li>Renalytix Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnlx#NASDAQ">RNLX</a>) climbed 26.5% to $1.05 after the company announced that effective Mar. 1, the US approved adding the company&#39;s kidneyintelX.dkd to its 10-year Governmentwide Acquisition Contract.</li>
<li>Tutor Perini Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tpc#NYSE">TPC</a>) gained 26% to $11.64 following fourth-quarter results.</li>
<li>Bright Scholar Education Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bedu#NYSE">BEDU</a>) gained 25.3% to $2.3178.</li>
<li>C3.ai, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ai#NYSE">AI</a>) shares rose 24.6% to $37.00 after the company reported better-than-expected third-quarter financial results.</li>
<li>Sterling Check Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ster#NASDAQ">STER</a>) jumped 24.6% to $15.49 after the company agreed to be acquired by First Advantage for approximately $2.2 billion, including outstanding debt.</li>
<li>Adial Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adil#NASDAQ">ADIL</a>) gained 24% to $2.00. Adial Pharmaceuticals was awarded a new patent covering AD04 for the potential treatment of opioid use disorder.</li>
<li>Revance Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvnc#NASDAQ">RVNC</a>) jumped 24% to $7.02 after the company reported better-than-expected quarterly financial results.</li>
<li>Latham Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swim#NASDAQ">SWIM</a>) climbed 22.8% to $3.36.</li>
<li>Avidity Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rna#NASDAQ">RNA</a>) jumped 22.5% to $18.70. Avidity Biosciences announced an oversubscribed $400 million private placement.</li>
<li>Pure Storage, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pstg#NYSE">PSTG</a>) rose 21.9% to $51.35 after the company reported better-than-expected fourth-quarter financial results and issued first-quarter revenue guidance above estimates. Also, UBS maintained a Neutral rating on the stock and raised its price target from $38 to $44.</li>
<li>Duolingo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duol#NASDAQ">DUOL</a>) gained 21.6% to $237.82 after the company reported better-than-expected fourth-quarter financial results and issued strong guidance.</li>
<li>Okta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/okta#NASDAQ">OKTA</a>) shares rose 19.8% to $104.55 after the company reported better-than-expected fourth-quarter financial results and issued strong guidance.</li>
<li>Mersana Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrsn#NASDAQ">MRSN</a>) gained 19.5% to $5.80 after the company reported fourth-quarter financial results.</li>
<li>Establishment Labs Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/esta#NASDAQ">ESTA</a>) rose 17.8% to $45.31 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Montrose Environmental Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/meg#NYSE">MEG</a>) gained 16.7% to $38.52 following quarterly results.</li>
<li>ORIC Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oric#NASDAQ">ORIC</a>) climbed 16.1% to $13.65.</li>
<li>SunOpta Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stkl#NASDAQ">STKL</a>) rose 15% to $6.91 following strong quarterly results.</li>
<li>TaskUs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/task#NASDAQ">TASK</a>) gained 14.4% to $14.17 following upbeat quarterly results.</li>
<li>Magnite, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgni#NASDAQ">MGNI</a>) rose 13.8% to $11.93 following strong quarterly results.</li>
<li>Indaptus Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/indp#NASDAQ">INDP</a>) rose 13.8% to $2.23.</li>
<li>Hayward Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hayw#NASDAQ">HAYW</a>) gained 13.7% to $14.88 following upbeat results.</li>
<li>Hormel Foods Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hrl#NYSE">HRL</a>) rose 12.8% to $34.81 after the company reported better-than-expected first-quarter earnings and reaffirmed FY24 outlook.</li>
<li>Nxu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxu#NASDAQ">NXU</a>) shares rose 9.2% to $0.7750. Nxu said it fully regained compliance with Nasdaq&#39;s continued listing requirements.</li>
<li>NFT Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mi#NYSE">MI</a>) shares jumped 7.9% to $0.2374.</li>
<li>Sprinklr, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cxm#NYSE">CXM</a>) gained 7.9% to $13.56. Sprinklr will replace Veradigm in S&amp;P SmallCap 600 effective prior to opening of trading on March 4, 2024.</li>
<li>Papa John&#39;s International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pzza#NASDAQ">PZZA</a>) climbed 6.8% to $74.89 following strong quarterly earnings.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>J-Long Group Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jl#NYSE">JL</a>) fell 46.3% to $6.86. J-Long Group declared a special cash dividend in aggregate amount of $6 million.</li>
<li>Golden Minerals Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aumn#NYSE">AUMN</a>) dipped 40.4% to $0.3163. Golden Minerals announced that it has elected to stop operations at its Velarde&ntilde;a Properties, located in Durango State, Mexico.</li>
<li>LivePerson, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lpsn#NASDAQ">LPSN</a>) shares declined 40% to $1.43 following fourth-quarter financial results.</li>
<li>NWTN Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nwtn#NASDAQ">NWTN</a>) fell 40% to $2.99.</li>
<li>Endava plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dava#NYSE">DAVA</a>) fell 40% to $38.31 following second-quarter earnings.</li>
<li>Kineta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ka#NASDAQ">KA</a>) fell 39.7% to $1.3801 as the company announced intention to explore strategic alternatives.</li>
<li>Ironwood Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/irwd#NASDAQ">IRWD</a>) fell 39% to $9.23 after the company&#39;s Phase 3 trial of once-weekly subcutaneous apraglutide did not meet two out of four key secondary endpoints.</li>
<li>Xometry, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xmtr#NASDAQ">XMTR</a>) fell 37.4% to $18.84 after the company reported fiscal fourth-quarter results and issued first-quarter guidance below estimates and disclosed a CFO transition.</li>
<li>Grifols, S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/grfs#NYSE">GRFS</a>) fell 36.7% to $5.91.</li>
<li>The Chemours Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cc#NYSE">CC</a>) shares declined 33.7% to $19.05. Chemours Company named Denise Dignam as the interim CEO and Matt Abbott as the interim CFO. The company also issued preliminary 2023 results.</li>
<li>Bakkt Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bkkt#NASDAQ">BKKT</a>) fell 33.4% to $0.6792 after the company announced two securities purchase agreements.</li>
<li>CommScope Holding Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/comm#NASDAQ">COMM</a>) dipped 30% to $1.2950 after the company reported financial fourth-quarter results below estimates.</li>
<li>Critical Metals Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crml#NASDAQ">CRML</a>) fell 25.2% to $11.43.</li>
<li>Gyre Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gyre#NASDAQ">GYRE</a>) dropped 22% to $19.34.</li>
<li>Lotus Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lot#NASDAQ">LOT</a>) fell 21.8% to $7.71.</li>
<li>BYND Cannasoft Enterprises Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcan#NASDAQ">BCAN</a>) shares fell 20.2% to $0.1621. BYND Cannasoft is entering into production agreements for its EZ-G Device.</li>
<li>Snowflake Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snow#NYSE">SNOW</a>) shares tumbled 20.1% to $183.81. Snowflake reported upbeat earnings for its fourth quarter. The company said CEO Frank Slootman has decided to retire from his role as CEO but will continue to serve as chairman of the board. Sridhar Ramaswamy has been appointed as CEO and a member of the board, effective immediately.</li>
<li>Schr&ouml;dinger, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sdgr#NASDAQ">SDGR</a>) shares declined 19.9% to $25.12 after the company reported mixed fourth-quarter financial results.</li>
<li>Castle Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cstl#NASDAQ">CSTL</a>) fell 18.7% to $19.83 following fourth-quarter financial results.</li>
<li>bluebird bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blue#NASDAQ">BLUE</a>) fell 18.2% to $1.3750.</li>
<li>Inari Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nari#NASDAQ">NARI</a>) shares fell 18.1% to $47.50 after posting a loss for the fourth quarter.</li>
<li>WW International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ww#NASDAQ">WW</a>) fell 17.9% to $3.1350 after the company reported fourth-quarter financial results and announced that director Oprah Winfrey has decided not to stand for re-election at the company&#39;s upcoming annual meeting of shareholders.</li>
<li>uniQure N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qure#NASDAQ">QURE</a>) fell 16.7% to $5.57. Goldman Sachs analyst Salveen Richter downgraded uniQure from Buy to Neutral and lowered the price target from $63 to $8.</li>
<li>Amarin Corporation plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amrn#NASDAQ">AMRN</a>) fell 16.7% to $1.09 following quarterly results.</li>
<li>DoubleVerify Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dv#NYSE">DV</a>) declined 16.6% to $32.71 after the company reported fourth quarter financial results.</li>
<li>Shoals Technologies Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/shls#NASDAQ">SHLS</a>) shares dipped 16.3% to $12.89 after the company reported worse-than-expected fourth-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Milestone Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mist#NASDAQ">MIST</a>) shares fell 16% to $1.7897 after announcing a proposed public offering of common shares and pre-funded warrants.</li>
<li>COMPASS Pathways plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmps#NASDAQ">CMPS</a>) fell 16% to $10.40 following a wider-than-expected quarterly loss.</li>
<li>FIGS, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/figs#NYSE">FIGS</a>) shares fell 15.4% to $5.10 after the company reported mixed quarterly financial results.</li>
<li>The Lion Electric Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lev#NYSE">LEV</a>) dipped 12.6% to $1.46 following fourth quarter financial results.</li>
<li>Cytek Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctkb#NASDAQ">CTKB</a>) fell 12.2% to $7.67 following fourth quarter financial results.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) shares fell 11.1% to $4.4350 following quarterly results.</li>
<li>Titan International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/twi#NYSE">TWI</a>) fell 10% to $12.73 following weak sales.</li>
<li>IonQ, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ionq#NYSE">IONQ</a>) shares declined 7.2% to $10.45 after the company reported mixed fourth quarter financial results.</li>
<li>Array Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arry#NASDAQ">ARRY</a>) fell 5.8% to $13.27.</li>
<li>Bath &amp; Body Works, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbwi#NASDAQ">BBWI</a>) fell 5.2% to $45.80 after the company reported fourth-quarter earnings and issued worse-than-expected FY24 outlook. It also authorized $500 million stock buyback.</li>
<li>NetEase, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntes#NASDAQ">NTES</a>) shares fell 3.7% to $108.03 after the company reported financial fourth-quarter results below estimates.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/02/37390717/nvidia-to-rally-around-27-here-are-10-top-analyst-forecasts-for-thursday"> NVIDIA To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday</a>

Intraday Update

Movers

Trading Ideas

ADIL

AGFY

AMRN

ARRY

BBWI

BCAN

BEDU

BFLY

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BLUE

CMPS

COMM

CRML

CSTL

CTKB

DAVA

DUOL

ENVB

ESTA

FIGS

GRFS

GYRE

HAYW

IHRT

INDP

INSG

IONQ

IRWD

LPSN

MGNI

MIST

MRSN

NARI

NTES

NWTN

OCEA

OKTA

ORIC

PSTG

PZZA

QURE

RNLX

RVNC

SCTL

SDGR

SHLS

SIDU

SNOW

STER

STKL

SWIM

TASK

VERX

VLCN

XMTR

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

WIIM

Golden Minerals shares are trading lower after the company announced it stopped mining operations at its Velardeña Properties.

Golden Minerals Company ("Golden Minerals," "Golden" or the "Company") (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AUMN#TSX">AUMN</a>) has announced that it has elected to stop operations at its Velardeña Properties, located in Durango State, Mexico.
The Company restarted mining operations at Velardeña in late December 2023, with the goal of progressively increasing production at the mine during the first half of 2024 until it achieved positive cash flow. The initial performance of the mine and processing plant during the course of the initial several months of production has not achieved the results projected by the Company. In light of the Company's decision to cease mining operations, the Company intends to evaluate potential alternatives for the Velardeña Properties, which may include a sale of properties or winding up of certain of the Company's Mexico operations.

TSX:AUMN

Reported Earlier, Golden Minerals Stops Mining Operations At Its Velardeña Properties, Located In Durango State, Mexico

Top Stories for Jan. 23, 2024:
1. BHP Xplor announced a second accelerator program to assist early-stage mineral exploration companies necessary to support the broader energy transition.
The program includes six companies pulled from over 500 applicants that will receive a grant of up to $500,000 and access to a network of internal and external industry experts to support their development across technical, business and operational facets.
The six companies chosen are:
<ol>
<li>Longreach Mineral: A private company innovating in mineral exploration using petroleum expertise and AI for new tier 1 deposits.</li>
<li>East Star Resources (LSE: EST): A U.K.-based company exploring copper and metals in Kazakhstan.</li>
<li>Pallas Resources: A private firm focusing on large-scale copper, gold, nickel sulfide and lithium in Kazakhstan.</li>
<li>Hamelin Gold Limited (ASX: HMG): An Australian mineral exploration firm targeting the West Tanami Gold Project in Western Australia.</li>
<li>Cobre Limited (ASX: CBE): An Australian-listed company specializing in copper and base metals exploration in Botswana.</li>
<li>Equivest Minerals: A private company utilizing technology and machine learning for locating major metal deposits.</li>
</ol>
2. Golden Minerals Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aumn#NYSE">AUMN</a>) announced that it began silver-gold mining operations at its Velarde&ntilde;a Properties in Mexico.
The company started mining six stopes and will steadily increase production to roughly 150 tons per day in March and approximately 325 tons per day in Q2.
The news follows an announcement in November that the Velarde&ntilde;a Properties began producing gold-rich pyrite flotation concentrates from material that had been stockpiled at the end of 2015.
3. Ramaco Resources, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/metc#NASDAQ">METC</a>) announced that it hired Dr. Alex Moyes as director of Critical Minerals and Planning to oversee its rare earth element operations and manage the geological and chemical assessment at Ramaco&#39;s Brook Mine in Wyoming.
Last year, the company said the mine could contain the largest unconventional deposit of rare earth elements discovered in the United States, and initial findings determined that it contains high concentrations of heavy and medium magnetic rare earth elements.
Chairman and CEO Randall Atkins: &quot;The Brook Mine will potentially be the first magnetic rare earth element mine opened in the United States in decades, and therefore presents an exciting but formidable opportunity.&hellip; Alex Moyes is a brilliant geologist, manager and engineer. We&#39;re proud he will be joining us to work alongside the Department of Energy&#39;s national laboratories to ensure the development path forward is built on a solid scientific, geological and techno-economic foundation.&quot;
4. Keybanc analyst Philip Gibbs <a href="https://www.benzinga.com/quote/USAP/analyst-ratings">maintained an Overweight rating</a> on Universal Stainless (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/usap#NASDAQ">USAP</a>) and raised his price target from $19 to $21.
Now Read:&nbsp;<a href="https://www.benzinga.com/markets/asia/24/01/36745956/alibaba-springs-back-to-life-as-co-founders-scoop-up-shares-its-jack-ma-hot-for-his-stock">Alibaba Springs Back To Life As Co-Founders Scoop Up Shares: &#39;It&#39;s Jack Ma &mdash; Hot For His Stock&#39;</a>
Photo: Shutterstock

METC

USAP

BHP Xplor's Second Accelerator; Golden Minerals Mines In Mexico; Ramaco Hires Director; Universal Stainless's Price Boost

HC Wainwright &amp; Co. analyst Heiko Ihle maintains Golden Minerals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AUMN#AMEX">AUMN</a>) with a Buy and lowers the price target from $9 to $3.1.

Price Target

Analyst Ratings

HC Wainwright & Co. Maintains Buy on Golden Minerals, Lowers Price Target to $3.1

Golden Minerals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AUMN#AMEX">AUMN</a>) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.50) by 24 percent. This is a 24 percent increase over losses of $(0.50) per share from the same period last year.

Golden Minerals Q3 EPS $(0.38) Compared With  $(0.40) YoY, Net Operating Margin Was Negative $0.8M

Golden Minerals Company ("Golden Minerals", "Golden" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AUMN#NYSE">AUMN</a>, TSX:<a class="ticker" href="https://www.benzinga.com/stock/AUMN#TSX">AUMN</a>) is pleased to announce the pricing of its public offering of an aggregate of 6,000,000 shares of its common stock (or common stock equivalents in lieu thereof), Series A warrants to purchase up to 6,000,000 shares of common stock and&nbsp; Series B warrants to purchase up to 3,000,000 shares of common stock, at a public offering price of $0.70 per share of common stock (or common stock equivalent in lieu thereof) and accompanying warrants. The Series A warrants will have an exercise price of $0.70 per share, will be exercisable immediately and will expire five years after the initial exercise date, and the Series B warrants will have an exercise price of $0.70 per share, will be exercisable immediately and will expire 18 months after the initial exercise date.&nbsp; The offering is expected to close on or about November 8, 2023, subject to the satisfaction of customary closing conditions.&nbsp;
H.C. Wainwright &amp; Co. is acting as the exclusive placement agent for the offering.
The gross proceeds from the offering are expected to be approximately $4.2 million, prior to deducting placement agent's fees and other offering expenses payable by Golden. Golden intends to use the net proceeds from the offering for working capital and other general corporate purposes.

Offerings

Golden Minerals Announces $4.2M Public Offering

The most overbought stocks in the materials sector presents an opportunity to go short on these overvalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi"> RSI is above 70.</a>
Here&rsquo;s the latest list of major overbought players in this sector.
<h3>Ramaco Resources, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/metc#NASDAQ">METC</a>)</h3>
<ul>
<li>Ramaco Resources updated its third-quarter guidance. The company said it now expects adjusted third-quarter earnings to be between 42 cents and 45 cents per share, representing a potential increase of 160% at the high end compared to the second quarter. Ramaco will report third-quarter earnings after the market close on Nov. 7. The company&rsquo;s stock has a <a href="https://www.benzinga.com/quote/METC">52-week high of $12.81. </a>.</li>
<li>RSI Value: 76.01</li>
<li>METC Price Action: Shares of Ramaco Resources fell 1.1% to close at $12.42 on Wednesday.</li>
</ul>
<h3>Gold Fields Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gfi#NYSE">GFI</a>)</h3>
<ul>
<li>JP Morgan recently upgraded the stock from Underweight to Neutral and announced a $14 price target. The company&rsquo;s <a href="https://www.benzinga.com/quote/GFI"> stock has a 52-week high </a> of $17.78.</li>
<li>RSI Value: 72.24</li>
<li>GFI Price Action: Shares of Gold Fields fell 0.8% to close at $14.22 on Wednesday.</li>
</ul>
<h3>Golden Minerals Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aumn#NYSE">AUMN</a>)</h3>
<ul>
<li>The company&rsquo;s stock jumped around 100% over the past month. The company has a <a href="https://www.benzinga.com/quote/AUMN"> 52-week high </a> of $8.00.</li>
<li>RSI Value: 83.38</li>
<li>AUMN Price Action: Shares of Golden Minerals jumped 47.2% to close at $1.36 on Wednesday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/10/35307291/blend-labs-and-3-other-stocks-under-3-insiders-are-buying"> Blend Labs And 3 Other Stocks Under $3 Insiders Are Buying </a>

Short Ideas

Pre-Market Outlook

Top 3 Materials Stocks You May Want To Dump This Month

Golden Minerals Company Files An Updated Technical Report For Preliminary Economic Assessment Update Of Velardeña Properties

Golden Minerals Company shares are trading higher after the company announced the NYSE accepted its business plan to regain listing compliance.

Golden Minerals Company (&quot;Golden Minerals,&quot; &quot;Golden&quot; or the &quot;Company&quot;) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AUMN#TSX">AUMN</a>) announced today that the NYSE American (the &quot;NYSE&quot;) has accepted the Company&#39;s business plan to regain compliance with the continued listing standards set forth in Section 1003(a)(iii) of the NYSE American Company Guide.
As previously disclosed, on June 6, 2023, the Company received written notice from the NYSE that the Company was not in compliance with Section 1003(a)(iii) which requires a listed company to have stockholders&#39; equity of at least (US)&nbsp;$6 million&nbsp;when such issuer has sustained losses from continuing operations and/or net losses in its five most recent fiscal years. The Company reported stockholders&#39; equity of&nbsp;$4.1 million&nbsp;as of March 31, 2023 and&nbsp;$5.6 million&nbsp;as of June 30, 2023. On August 22, 2023, the NYSE accepted the Company&#39;s plan to regain compliance and has granted to the Company a cure period of up to 18 months from the original notice of non-compliance, or until December 6, 2024.
The listing of the Company&#39;s common stock will continue pursuant to an extension during the plan period, during which time the Company will be subject to periodic review to determine whether it is making progress consistent with the accepted plan. Failure to make progress consistent with the plan or to regain compliance with the continued listing standards by December 6, 2024 could result in the Company&#39;s shares of common stock being delisted from the NYSE American.

Reported Earlier, Golden Minerals Receives NYSE Acceptance Of Plan To Regain Listing Compliance

<h1>&nbsp;</h1>
Friday&#39;s session saw 59 companies set new 52-week lows.
<h2>Interesting Facts About Today&#39;s 52-Week Lows:</h2>
<ul>
<li>Bristol-Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) was the largest firm by market cap to set a new 52-week low.</li>
<li>BitNile Metaverse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNMV#NASDAQ">BNMV</a>) was the smallest company in terms of market cap to set a new 52-week low.</li>
<li>Tonix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) saw the largest move of the companies, as shares plummetted 38.2% to hit a new 52-week low.</li>
<li>ClearPoint Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>)&#39;s stock bounced back the most, actually rising 0.0% after reaching its new 52-week low.</li>
</ul>
The following stocks created new 52-week lows on Friday:
<ul>
<li>Bristol-Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) shares were up 0.07% for the day, having made a 52-week low of $60.05.</li>
<li>TC Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRP#NYSE">TRP</a>) shares were down 4.72% for the day, having made a 52-week low of $33.05.</li>
<li>Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) shares were down 10.61% for the day, having made a 52-week low of $145.67.</li>
<li>Apellis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) shares made a new 52-week low of $27.90 on Friday. The stock was down 5.79% for the day.</li>
<li>NovoCure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) shares set a new 52-week low of $32.51. The stock traded down 2.86%.</li>
<li>Clearway Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWEN#NYSE">CWEN</a>) stock hit a yearly low of $26.30. The stock was down 0.26% for the day.</li>
<li>TELUS Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIXT#NYSE">TIXT</a>) shares set a new 52-week low of $9.31. The stock traded down 0.21%.</li>
<li>Impinj (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>) stock hit a new 52-week low of $65.47. The stock was down 5.13% on the session.</li>
<li>Maravai LifeSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVI#NASDAQ">MRVI</a>) stock broke to a new 52-week low of $11.12 on Friday. Shares of the company traded up 0.39%.</li>
<li>Baijiayun Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RTC#NASDAQ">RTC</a>) shares fell to $6.29 on Friday, setting a new 52-week low with a shift of up 3.69%.</li>
<li>2seventy bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSVT#NASDAQ">TSVT</a>) stock achieved a new 52-week low on Friday morning, hitting $7.46 and moving down 7.08%.</li>
<li>Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) shares set a new 52-week low of $6.72. The stock traded up 0.87%.</li>
<li>TPI Composites (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPIC#NASDAQ">TPIC</a>) shares reached a new 52-week low of $5.56 on Friday morning, moving down 6.52%.</li>
<li>Prelude Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRLD#NASDAQ">PRLD</a>) stock hit $3.96 on Friday morning, setting a new 52-week low for a change of down 3.12%.</li>
<li>Rimini Street (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMNI#NASDAQ">RMNI</a>) stock set a new 52-week low of $2.26 on Friday, moving down 2.33%.</li>
<li>Adaptimmune Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>) shares moved up 2.56% on Friday to hit a new 52-week low of $0.87, drifting up 2.56%.</li>
<li>NGM Biopharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGM#NASDAQ">NGM</a>) stock drifted down 0.44% on Friday morning to hit a new 52-week low of $2.23.</li>
<li>Nouveau Monde Graphite (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NMG#NYSE">NMG</a>) stock set a new 52-week low of $2.73 on Friday, moving down 4.83%.</li>
<li>Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) shares set a new yearly low of $3.50 this morning. The stock was down 1.87% on the session.</li>
<li>ClearPoint Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) shares set a new 52-week low of $6.25. The stock traded 0.0% (flat).</li>
<li>Electrovaya (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVA#NASDAQ">ELVA</a>) stock set a new 52-week low of $4.11 on Friday, moving down 3.17%.</li>
<li>NioCorp Developments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NB#NASDAQ">NB</a>) stock hit $4.35 on Friday morning, setting a new 52-week low for a change of up 1.37%.</li>
<li>Aadi Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AADI#NASDAQ">AADI</a>) stock hit a yearly low of $5.17. The stock was down 3.35% for the day.</li>
<li>G1 Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTHX#NASDAQ">GTHX</a>) stock set a new 52-week low of $2.31 on Friday, moving up 1.29%.</li>
<li>Eargo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAR#NASDAQ">EAR</a>) shares hit a yearly low of $3.88. The stock was up 2.31% on the session.</li>
<li>MSP Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIFW#NASDAQ">LIFW</a>) stock hit a new 52-week low of $0.20. The stock was up 10.04% on the session.</li>
<li>CEL-SCI (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVM#AMEX">CVM</a>) shares hit a yearly low of $1.53. The stock was down 9.94% on the session.</li>
<li>Delta Apparel (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/DLA#AMEX">DLA</a>) shares reached a new 52-week low of $8.71 on Friday morning, moving down 0.4%.</li>
<li>Airgain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRG#NASDAQ">AIRG</a>) stock hit a new 52-week low of $4.61. The stock was down 2.71% on the session.</li>
<li>Leap Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPTX#NASDAQ">LPTX</a>) stock set a new 52-week low of $2.26 on Friday, moving up 5.79%.</li>
<li>Phoenix New Media (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FENG#NYSE">FENG</a>) stock hit a yearly low of $1.63. The stock was down 6.78% for the day.</li>
<li>Strong Global (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGE#AMEX">SGE</a>) shares hit a yearly low of $2.40. The stock was up 2.0% on the session.</li>
<li>Addentax Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) shares made a new 52-week low of $3.42 on Friday. The stock was down 0.83% for the day.</li>
<li>Tonix Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>) shares made a new 52-week low of $1.01 on Friday. The stock was down 38.2% for the day.</li>
<li>Golden Minerals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AUMN#AMEX">AUMN</a>) shares moved down 3.88% on Friday to hit a new 52-week low of $1.20, drifting down 3.88%.</li>
<li>China Jo-Jo Drugstores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CJJD#NASDAQ">CJJD</a>) shares set a new yearly low of $0.36 this morning. The stock was down 0.5% on the session.</li>
<li>Precipio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPO#NASDAQ">PRPO</a>) stock hit a new 52-week low of $0.31. The stock was down 0.25% on the session.</li>
<li>ABVC BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVC#NASDAQ">ABVC</a>) stock hit a yearly low of $2.61. The stock was down 14.19% for the day.</li>
<li>Powerbridge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) stock drifted down 5.04% on Friday morning to hit a new 52-week low of $0.26.</li>
<li>Siyata Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYTA#NASDAQ">SYTA</a>) shares set a new 52-week low of $0.04. The stock traded down 7.05%.</li>
<li>Applied UV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUVI#NASDAQ">AUVI</a>) stock drifted down 2.37% on Friday morning to hit a new 52-week low of $0.80.</li>
<li>TRACON Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) shares fell to $0.26 on Friday, setting a new 52-week low with a shift of down 3.18%.</li>
<li>Micromobility com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCOM#NASDAQ">MCOM</a>) stock hit a new 52-week low of $0.07. The stock was down 7.85% on the session.</li>
<li>FOXO Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#AMEX">FOXO</a>) stock drifted up 0.89% on Friday morning to hit a new 52-week low of $0.13.</li>
<li>Lixte Biotech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) stock dropped to a yearly low on Friday of $3.23. Shares traded down 7.61%.</li>
<li>Bellerophon Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLPH#NASDAQ">BLPH</a>) stock set a new 52-week low of $0.39 on Friday, moving down 3.71%.</li>
<li>Adamis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMP#NASDAQ">ADMP</a>) shares were down 7.41% for the day, having made a 52-week low of $1.45.</li>
<li>Ault Alliance (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AULT#AMEX">AULT</a>) stock set a new 52-week low of $2.78 on Friday, moving down 1.68%.</li>
<li>C3is (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISS#NASDAQ">CISS</a>) stock hit $0.55 on Friday morning, setting a new 52-week low for a change of up 2.42%.</li>
<li>EBET (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBET#NASDAQ">EBET</a>) shares set a new 52-week low of $0.08. The stock traded down 0.29%.</li>
<li>Gaucho Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINO#NASDAQ">VINO</a>) shares set a new 52-week low of $0.48. The stock traded down 3.92%.</li>
<li>Kiromic BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRBP#NASDAQ">KRBP</a>) stock hit a yearly low of $2.46. The stock was down 3.68% for the day.</li>
<li>Avalo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) shares set a new 52-week low of $0.18. The stock traded down 9.71%.</li>
<li>G Medical Innovations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMVD#NASDAQ">GMVD</a>) shares were down 14.96% for the day, having made a 52-week low of $0.27.</li>
<li>Ucommune International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UK#NASDAQ">UK</a>) shares set a new 52-week low of $0.33. The stock traded down 4.81%.</li>
<li>Esports Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMBL#NASDAQ">GMBL</a>) shares made a new 52-week low of $0.41 on Friday. The stock was down 1.49% for the day.</li>
</ul>
Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. <a href="https://pro.benzinga.com/?afmc=2a&amp;utm_source=benzinga.com&amp;utm_medium=web&amp;utm_campaign=premium_products">Learn more here</a>.

Options

AADI

ABVC

ADAP

ADMP

AIRG

APLS

ATXG

AULT

AUVI

AVTX

BLPH

BNMV

CISS

CJJD

CLPT

CSLR

CWEN

EBET

ELVA

ENPH

FENG

FOXO

GMBL

GMVD

GTHX

KRBP

LIFW

LIXT

LPTX

MCOM

MRVI

NVCR

PBTS

PRLD

PRPO

RMNI

SYTA

TCON

TIXT

TNXP

TPIC

TSVT

VINO

Stocks That Hit 52-Week Lows On Friday

<h1>&nbsp;</h1>
During Thursday, 56 stocks hit new 52-week lows.
<h2>52-Week Low Highlights:</h2>
<ul>
<li>Bristol-Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) was the biggest company in terms of market cap to set a new 52-week low.</li>
<li>American Rebel Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) was the smallest company in terms of market cap to set a new 52-week low.</li>
<li>View (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIEW#NASDAQ">VIEW</a>)&#39;s stock moved significantly downwards, trading down 5230.71% to reach a new 52-week low.</li>
<li>CBL International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BANL#NASDAQ">BANL</a>) saw the sharpest rebound, as shares ascended 0.09%, reversing after hiting a new 52-week low.</li>
</ul>
Stocks dropping to new 52-week lows on Thursday:
<ul>
<li>Bristol-Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) stock broke to a new 52-week low of $60.38 on Thursday. Shares of the company traded down 2.93%.</li>
<li>TC Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRP#NYSE">TRP</a>) stock hit a new 52-week low of $36.41. The stock was down 1.73% on the session.</li>
<li>NovoCure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) shares moved down 12.74% on Thursday to hit a new 52-week low of $34.66, drifting down 12.74%.</li>
<li>TELUS Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIXT#NYSE">TIXT</a>) shares hit a yearly low of $9.58. The stock was down 1.34% on the session.</li>
<li>MaxLinear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXL#NASDAQ">MXL</a>) stock hit $22.55 on Thursday morning, setting a new 52-week low for a change of down 22.53%.</li>
<li>Nexa Res (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEXA#NYSE">NEXA</a>) shares set a new 52-week low of $4.13. The stock traded down 1.17%.</li>
<li>Shyft Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHYF#NASDAQ">SHYF</a>) stock broke to a new 52-week low of $14.14 on Thursday. Shares of the company traded down 29.01%.</li>
<li>uniQure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QURE#NASDAQ">QURE</a>) shares set a new 52-week low of $9.37. The stock traded up 0.63%.</li>
<li>Sharecare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHCR#NASDAQ">SHCR</a>) shares fell to $1.15 on Thursday, setting a new 52-week low with a shift of down 9.33%.</li>
<li>Luxfer Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXFR#NYSE">LXFR</a>) stock hit a yearly low of $12.53. The stock was down 6.72% for the day.</li>
<li>Stoke Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STOK#NASDAQ">STOK</a>) shares were up 0.17% for the day, having made a 52-week low of $5.88.</li>
<li>Prelude Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRLD#NASDAQ">PRLD</a>) shares set a new 52-week low of $4.06. The stock traded down 0.73%.</li>
<li>XOMA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XOMA#NASDAQ">XOMA</a>) stock achieved a new 52-week low on Thursday morning, hitting $15.22 and moving up 1.1%.</li>
<li>FibroGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) stock hit a yearly low of $1.82. The stock was down 2.14% for the day.</li>
<li>Kezar Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZR#NASDAQ">KZR</a>) stock hit $2.19 on Thursday morning, setting a new 52-week low for a change of down 2.88%.</li>
<li>Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) stock drifted down 7.25% on Thursday morning to hit a new 52-week low of $4.15.</li>
<li>NioCorp Developments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NB#NASDAQ">NB</a>) shares set a new 52-week low of $4.52. The stock traded down 0.22%.</li>
<li>Beyond Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) stock dropped to a yearly low on Thursday of $3.31. Shares traded down 2.9%.</li>
<li>Mersana Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRSN#NASDAQ">MRSN</a>) stock drifted down 76.38% on Thursday morning to hit a new 52-week low of $0.80.</li>
<li>Intensity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTS#NASDAQ">INTS</a>) shares reached a new 52-week low of $5.40 on Thursday morning, moving down 3.89%.</li>
<li>MSP Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIFW#NASDAQ">LIFW</a>) shares set a new yearly low of $0.20 this morning. The stock was down 7.16% on the session.</li>
<li>Celularity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELU#NASDAQ">CELU</a>) shares were up 3.03% for the day, having made a 52-week low of $0.34.</li>
<li>Integra Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ITRG#AMEX">ITRG</a>) shares moved down 1.45% on Thursday to hit a new 52-week low of $0.88, drifting down 1.45%.</li>
<li>CBL International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BANL#NASDAQ">BANL</a>) shares were down 0.09% for the day, having made a 52-week low of $1.59.</li>
<li>Nautilus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLS#NYSE">NLS</a>) stock achieved a new 52-week low on Thursday morning, hitting $1.03 and moving down 2.8%.</li>
<li>Yellow (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YELL#NASDAQ">YELL</a>) stock set a new 52-week low of $0.43 on Thursday, moving down 43.14%.</li>
<li>Leap Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPTX#NASDAQ">LPTX</a>) shares moved down 6.2% on Thursday to hit a new 52-week low of $2.38, drifting down 6.2%.</li>
<li>View (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIEW#NASDAQ">VIEW</a>) shares set a new yearly low of $6.08 this morning. The stock was up 5230.71% on the session.</li>
<li>ATI Physical Therapy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATIP#NYSE">ATIP</a>) stock hit a yearly low of $6.12. The stock was down 7.8% for the day.</li>
<li>Purple Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPBT#NASDAQ">PPBT</a>) stock hit a yearly low of $1.14. The stock was down 1.69% for the day.</li>
<li>Acurx Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACXP#NASDAQ">ACXP</a>) shares fell to $1.80 on Thursday, setting a new 52-week low with a shift of down 4.71%.</li>
<li>Yunji (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YJ#NASDAQ">YJ</a>) stock hit $1.05 on Thursday morning, setting a new 52-week low for a change of down 1.87%.</li>
<li>Better Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTTX#NASDAQ">BTTX</a>) stock dropped to a yearly low on Thursday of $0.57. Shares traded down 4.29%.</li>
<li>BioCardia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCDA#NASDAQ">BCDA</a>) shares hit a yearly low of $0.88. The stock was down 6.61% on the session.</li>
<li>Capstone Green Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGRN#NASDAQ">CGRN</a>) stock hit a yearly low of $0.97. The stock was down 11.31% for the day.</li>
<li>Addentax Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) stock drifted down 2.12% on Thursday morning to hit a new 52-week low of $3.65.</li>
<li>Lytus Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYT#NASDAQ">LYT</a>) shares moved down 12.74% on Thursday to hit a new 52-week low of $0.31, drifting down 12.74%.</li>
<li>Greenbrook TMS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBNH#NASDAQ">GBNH</a>) shares set a new 52-week low of $0.23. The stock traded up 2.74%.</li>
<li>ABVC BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVC#NASDAQ">ABVC</a>) stock set a new 52-week low of $3.26 on Thursday, moving down 37.59%.</li>
<li>Golden Minerals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AUMN#AMEX">AUMN</a>) stock drifted down 1.55% on Thursday morning to hit a new 52-week low of $1.22.</li>
<li>Powerbridge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) shares hit a yearly low of $0.29. The stock was down 4.59% on the session.</li>
<li>Freight Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRGT#NASDAQ">FRGT</a>) stock hit a new 52-week low of $0.63. The stock was down 1.68% on the session.</li>
<li>Takung Art (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TKAT#AMEX">TKAT</a>) stock set a new 52-week low of $0.18 on Thursday, moving down 15.97%.</li>
<li>Cyclerion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCN#NASDAQ">CYCN</a>) shares set a new 52-week low of $2.88. The stock traded down 2.68%.</li>
<li>Ault Alliance (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AULT#AMEX">AULT</a>) shares set a new 52-week low of $2.95. The stock traded down 10.86%.</li>
<li>C3is (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISS#NASDAQ">CISS</a>) stock broke to a new 52-week low of $0.62 on Thursday. Shares of the company traded down 3.64%.</li>
<li>Avalo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) shares set a new 52-week low of $0.21. The stock traded down 7.75%.</li>
<li>Aditxt (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTX#NASDAQ">ADTX</a>) shares moved up 0.1% on Thursday to hit a new 52-week low of $0.39, drifting up 0.1%.</li>
<li>BitNile Metaverse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNMV#NASDAQ">BNMV</a>) shares fell to $0.74 on Thursday, setting a new 52-week low with a shift of down 7.99%.</li>
<li>Esports Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMBL#NASDAQ">GMBL</a>) stock achieved a new 52-week low on Thursday morning, hitting $0.42 and moving down 7.98%.</li>
<li>American Rebel Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) shares were down 4.93% for the day, having made a 52-week low of $1.56.</li>
</ul>
Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. <a href="https://pro.benzinga.com/?afmc=2a&amp;utm_source=benzinga.com&amp;utm_medium=web&amp;utm_campaign=premium_products">Click here to learn more</a>.

ACXP

ADTX

AREB

ATIP

BANL

BCDA

BTTX

CELU

CGRN

CYCN

FGEN

FRGT

GBNH

INTS

ITRG

LXFR

PPBT

SHCR

SHYF

STOK

TKAT

VIEW

XAIR

XOMA

YELL

Stocks That Hit 52-Week Lows On Thursday

<h1>&nbsp;</h1>
On Monday, 70 companies achieved new lows for the year.
<h2>Interesting Facts About Today&#39;s 52-Week Lows:</h2>
<ul>
<li>Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) was the largest firm by market cap to set a new 52-week low.</li>
<li>9 Meters Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMTR#NASDAQ">NMTR</a>) was the smallest firm on a market cap basis to set a new 52-week low.</li>
<li>AppHarvest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPH#NASDAQ">APPH</a>) was the biggest loser, trading down 70.3% to reach its 52-week low.</li>
<li>SWK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKH#NASDAQ">SWKH</a>) was the biggest winner of the bunch, with shares actually trading up 0.0% after it rebounded from its new 52-week low.</li>
</ul>
On Monday, the following stocks hit new 52-week lows:
<ul>
<li>Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) stock broke to a new 52-week low of $171.94 on Monday. Shares of the company traded down 2.62%.</li>
<li>NovoCure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) stock broke to a new 52-week low of $37.92 on Monday. Shares of the company traded down 2.0%.</li>
<li>Apellis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) stock drifted down 2.66% on Monday morning to hit a new 52-week low of $32.75.</li>
<li>Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) shares were down 0.95% for the day, having made a 52-week low of $32.05.</li>
<li>Nu Skin Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUS#NYSE">NUS</a>) shares moved down 0.12% on Monday to hit a new 52-week low of $28.18, drifting down 0.12%.</li>
<li>Lifezone Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LZM#NYSE">LZM</a>) stock achieved a new 52-week low on Monday morning, hitting $9.03 and moving down 11.94%.</li>
<li>Avidity Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNA#NASDAQ">RNA</a>) stock drifted down 2.74% on Monday morning to hit a new 52-week low of $9.71.</li>
<li>Beneficient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BENF#NASDAQ">BENF</a>) stock drifted down 3.24% on Monday morning to hit a new 52-week low of $2.03.</li>
<li>uniQure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QURE#NASDAQ">QURE</a>) stock achieved a new 52-week low on Monday morning, hitting $9.72 and moving down 1.75%.</li>
<li>AnaptysBio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANAB#NASDAQ">ANAB</a>) shares hit a yearly low of $17.51. The stock was down 2.57% on the session.</li>
<li>Enanta Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTA#NASDAQ">ENTA</a>) shares moved down 2.87% on Monday to hit a new 52-week low of $18.17, drifting down 2.87%.</li>
<li>Compute Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPUH#NYSE">CPUH</a>) stock hit $9.70 on Monday morning, setting a new 52-week low for a change of down 0.28%.</li>
<li>BRC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRCC#NYSE">BRCC</a>) shares made a new 52-week low of $4.76 on Monday. The stock was down 2.44% for the day.</li>
<li>SWK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKH#NASDAQ">SWKH</a>) stock hit a new 52-week low of $16.10. The stock was 0.0% (flat) on the session.</li>
<li>FibroGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) shares fell to $1.98 on Monday, setting a new 52-week low with a shift of down 3.88%.</li>
<li>Inogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INGN#NASDAQ">INGN</a>) shares set a new 52-week low of $8.32. The stock traded down 2.43%.</li>
<li>Kodiak Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOD#NASDAQ">KOD</a>) shares made a new 52-week low of $2.77 on Monday. The stock was down 50.48% for the day.</li>
<li>Altimmune (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) stock hit a yearly low of $3.04. The stock was down 1.95% for the day.</li>
<li>ADC Therapeutics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADCT#NYSE">ADCT</a>) shares were down 3.87% for the day, having made a 52-week low of $1.35.</li>
<li>Carmell Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) stock dropped to a yearly low on Monday of $4.60. Shares traded down 11.03%.</li>
<li>CEL-SCI (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVM#AMEX">CVM</a>) stock achieved a new 52-week low on Monday morning, hitting $1.78 and moving down 8.88%.</li>
<li>Durect (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRRX#NASDAQ">DRRX</a>) stock dropped to a yearly low on Monday of $2.96. Shares traded up 0.98%.</li>
<li>Theratechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THTX#NASDAQ">THTX</a>) shares made a new 52-week low of $0.58 on Monday. The stock was down 11.97% for the day.</li>
<li>Airgain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRG#NASDAQ">AIRG</a>) shares set a new 52-week low of $4.76. The stock traded up 0.41%.</li>
<li>Westwater Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/WWR#AMEX">WWR</a>) stock dropped to a yearly low on Monday of $0.77. Shares traded up 2.81%.</li>
<li>Nautilus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLS#NYSE">NLS</a>) shares moved up 1.42% on Monday to hit a new 52-week low of $1.04, drifting up 1.42%.</li>
<li>Interactive Strength (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) shares moved down 7.57% on Monday to hit a new 52-week low of $2.00, drifting down 7.57%.</li>
<li>Purple Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPBT#NASDAQ">PPBT</a>) stock achieved a new 52-week low on Monday morning, hitting $1.18 and moving down 1.64%.</li>
<li>BioCardia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCDA#NASDAQ">BCDA</a>) stock hit a new 52-week low of $1.01. The stock was down 46.97% on the session.</li>
<li>Zivo Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZIVO#NASDAQ">ZIVO</a>) shares moved up 1.61% on Monday to hit a new 52-week low of $1.76, drifting up 1.61%.</li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) stock hit $1.11 on Monday morning, setting a new 52-week low for a change of down 1.74%.</li>
<li>Addentax Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) stock hit a new 52-week low of $3.83. The stock was down 5.69% on the session.</li>
<li>AERWINS Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWIN#NASDAQ">AWIN</a>) stock hit a new 52-week low of $0.25. The stock was down 6.54% on the session.</li>
<li>Cadrenal Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVKD#NASDAQ">CVKD</a>) stock dropped to a yearly low on Monday of $1.04. Shares traded down 12.34%.</li>
<li>Greenbrook TMS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBNH#NASDAQ">GBNH</a>) stock broke to a new 52-week low of $0.31 on Monday. Shares of the company traded down 9.81%.</li>
<li>60 Degrees (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTP#NASDAQ">SXTP</a>) shares reached a new 52-week low of $2.31 on Monday morning, moving down 11.61%.</li>
<li>Golden Minerals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AUMN#AMEX">AUMN</a>) stock achieved a new 52-week low on Monday morning, hitting $1.33 and moving down 2.84%.</li>
<li>GRI Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRI#NASDAQ">GRI</a>) shares set a new yearly low of $3.53 this morning. The stock was down 0.84% on the session.</li>
<li>Powerbridge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) stock drifted down 4.75% on Monday morning to hit a new 52-week low of $0.30.</li>
<li>Bio-Path Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) shares hit a yearly low of $1.17. The stock was down 2.5% on the session.</li>
<li>Taoping (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAOP#NASDAQ">TAOP</a>) shares set a new 52-week low of $0.47. The stock traded down 2.02%.</li>
<li>Siyata Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYTA#NASDAQ">SYTA</a>) shares reached a new 52-week low of $0.04 on Monday morning, moving down 5.47%.</li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) stock dropped to a yearly low on Monday of $0.51. Shares traded down 1.12%.</li>
<li>Micromobility com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCOM#NASDAQ">MCOM</a>) shares fell to $0.08 on Monday, setting a new 52-week low with a shift of down 4.92%.</li>
<li>ViewRay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAY#NASDAQ">VRAY</a>) shares set a new 52-week low of $0.04. The stock traded down 31.69%.</li>
<li>FOXO Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#AMEX">FOXO</a>) shares set a new 52-week low of $0.13. The stock traded down 3.13%.</li>
<li>Lixte Biotech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) shares set a new yearly low of $4.03 this morning. The stock was down 4.05% on the session.</li>
<li>iSun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISUN#NASDAQ">ISUN</a>) stock dropped to a yearly low on Monday of $0.33. Shares traded down 6.59%.</li>
<li>Shineco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SISI#NASDAQ">SISI</a>) shares reached a new 52-week low of $0.22 on Monday morning, moving down 7.5%.</li>
<li>C3is (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISS#NASDAQ">CISS</a>) shares fell to $0.70 on Monday, setting a new 52-week low with a shift of down 4.48%.</li>
<li>SuperCom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPCB#NASDAQ">SPCB</a>) stock drifted down 3.72% on Monday morning to hit a new 52-week low of $0.78.</li>
<li>Ra Medical Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RMED#AMEX">RMED</a>) shares hit a yearly low of $0.61. The stock was up 1.03% on the session.</li>
<li>ZyVersa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) shares reached a new 52-week low of $0.16 on Monday morning, moving down 12.55%.</li>
<li>Salarius Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRX#NASDAQ">SLRX</a>) stock hit a new 52-week low of $1.00. The stock was down 1.43% on the session.</li>
<li>Avalo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) shares were down 13.87% for the day, having made a 52-week low of $0.25.</li>
<li>Grom Social Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GROM#NASDAQ">GROM</a>) shares hit a yearly low of $0.29. The stock was down 11.11% on the session.</li>
<li>Aditxt (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTX#NASDAQ">ADTX</a>) shares were down 1.84% for the day, having made a 52-week low of $0.40.</li>
<li>E-Home Household Service (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) stock hit a new 52-week low of $0.10. The stock was down 11.83% on the session.</li>
<li>Esports Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMBL#NASDAQ">GMBL</a>) shares reached a new 52-week low of $0.56 on Monday morning, moving down 2.38%.</li>
<li>BitNile Metaverse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNMV#NASDAQ">BNMV</a>) shares hit a yearly low of $0.93. The stock was down 8.1% on the session.</li>
<li>Sigma Additive Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SASI#NASDAQ">SASI</a>) stock hit a yearly low of $0.19. The stock was down 12.17% for the day.</li>
<li>9 Meters Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMTR#NASDAQ">NMTR</a>) stock dropped to a yearly low on Monday of $0.12. Shares traded down 13.01%.</li>
</ul>
Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. <a href="https://pro.benzinga.com/?afmc=2a&amp;utm_source=benzinga.com&amp;utm_medium=web&amp;utm_campaign=premium_products">Click here to learn more</a>.

ADCT

Stocks That Hit 52-Week Lows On Monday